1. Home
  2. NDLS vs PMN Comparison

NDLS vs PMN Comparison

Compare NDLS & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDLS
  • PMN
  • Stock Information
  • Founded
  • NDLS 1995
  • PMN 2004
  • Country
  • NDLS United States
  • PMN Canada
  • Employees
  • NDLS N/A
  • PMN N/A
  • Industry
  • NDLS Restaurants
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • NDLS Consumer Discretionary
  • PMN Health Care
  • Exchange
  • NDLS Nasdaq
  • PMN Nasdaq
  • Market Cap
  • NDLS 34.3M
  • PMN 29.8M
  • IPO Year
  • NDLS 2013
  • PMN N/A
  • Fundamental
  • Price
  • NDLS $1.55
  • PMN $0.95
  • Analyst Decision
  • NDLS Strong Buy
  • PMN
  • Analyst Count
  • NDLS 2
  • PMN 0
  • Target Price
  • NDLS $3.00
  • PMN N/A
  • AVG Volume (30 Days)
  • NDLS 333.1K
  • PMN 43.9K
  • Earning Date
  • NDLS 03-06-2025
  • PMN 03-31-2025
  • Dividend Yield
  • NDLS N/A
  • PMN N/A
  • EPS Growth
  • NDLS N/A
  • PMN N/A
  • EPS
  • NDLS N/A
  • PMN N/A
  • Revenue
  • NDLS $495,817,000.00
  • PMN N/A
  • Revenue This Year
  • NDLS $0.28
  • PMN N/A
  • Revenue Next Year
  • NDLS N/A
  • PMN N/A
  • P/E Ratio
  • NDLS N/A
  • PMN N/A
  • Revenue Growth
  • NDLS N/A
  • PMN N/A
  • 52 Week Low
  • NDLS $0.55
  • PMN $0.87
  • 52 Week High
  • NDLS $2.62
  • PMN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • NDLS 63.25
  • PMN 52.16
  • Support Level
  • NDLS $1.44
  • PMN $0.88
  • Resistance Level
  • NDLS $1.68
  • PMN $1.03
  • Average True Range (ATR)
  • NDLS 0.15
  • PMN 0.06
  • MACD
  • NDLS -0.01
  • PMN 0.00
  • Stochastic Oscillator
  • NDLS 58.14
  • PMN 46.67

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: